Founded in 1885, Boehringer Ingelheim is one of the world’s largest pharmaceutical companies, generating €24.1 billion in net sales in 2022. With 176 affiliates, over 53,000 employees, and 25 R&D sites, the company operates across three main areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. As a global enterprise, Boehringer Ingelheim is focused on perfecting its payment platform to support diverse financial operations worldwide, ensuring efficiency and consistency across all payment types. Learn more at tispayments.com.

Join for free to read